In This Article:
-
Total Revenue: $479.9 million for 2024, up 94% from $247.6 million in 2023.
-
Adjusted EBITDA: Increased from $10.8 million in 2023 to $123.7 million in 2024, up over 1,000%.
-
Net Income: $52 million for 2024 compared to a loss of $46 million in 2023.
-
Patient Volume: Increased by 17% from 144,000 in 2023 to 168,000 in 2024.
-
Long-term Debt: Current portion increased from $10.8 million in 2023 to $14 million in 2024; net long-term debt decreased from $26 million in 2023 to $22 million in 2024.
-
Fourth-Quarter Revenue: $257.6 million, up 270% from $69.7 million in Q4 2023.
-
Fourth-Quarter Net Income: $61.7 million compared to a net loss of $31.6 million in Q4 2023.
-
Cash and Cash Equivalents: $44 million at the end of 2024, up from $22 million in 2023.
-
Accounts Receivable: $232 million at the end of 2024, up from $58.6 million in 2023.
-
Cash Flow from Operating Activities: Increased to $23.2 million in 2024 from $1 million in 2023.
-
Hospital Network: Expanded to 24 hospitals across 11 states in 2024.
Release Date: April 01, 2025
For the complete transcript of the earnings call, please refer to the full earnings call transcript.
Positive Points
-
Nutex Health Inc (NASDAQ:NUTX) reported a significant revenue increase of 94% for the full year of 2024, reaching $479.9 million compared to $247.6 million in 2023.
-
The company's adjusted EBITDA saw a remarkable growth of over 1,000%, rising from $10.8 million in 2023 to $123.7 million in 2024.
-
Net income for 2024 was $52 million, a substantial improvement from a loss of $46 million in 2023.
-
Patient volume increased by 17% in 2024, with mature hospitals contributing 6.5% to this growth.
-
Nutex Health Inc (NASDAQ:NUTX) successfully opened four new hospitals in 2024, expanding its network to 24 hospitals across 11 states.
Negative Points
-
The implementation of the No Surprises Act (NSA) has negatively impacted revenue per patient reimbursement, with insurer payments for emergency services dropping by roughly 30%.
-
The arbitration process, while beneficial, is costly, labor-intensive, and time-consuming, posing a financial and operational burden.
-
Despite the opening of new hospitals, the current portion of long-term debt increased from $10.8 million in 2023 to $14 million in 2024.
-
The arbitration process requires significant upfront costs, including Medicare administrative fees and arbitrator fees, which can be a financial strain.
-
The company faces challenges in maintaining low costs and aggressive debt management amidst expansion and operational adjustments.